Altis Full Face Mask
Respironics, Inc. · Decision date Sep 25, 2026
What did the FDA decide?
FDA recorded a substantially equivalent (SESE) decision on September 25, 2026 for the Altis Full Face Mask, submitted by Respironics, Inc. of Murrysville, Pennsylvania, under 510(k) number K261262. The device falls under the classification name Ventilator, Non-Continuous (Respirator), regulation number 868.5905, product code BZD, with anesthesiology as the regulation medical specialty and review panel. The application was received on April 16, 2026 and reviewed as a traditional 510(k) without third-party review.
SESE denotes 510(k) clearance rather than premarket approval. The public record identifies no predicate device, no summary statement content, and no specific component or changed item, so the technical basis for equivalence cannot be described from these sources. The available decision letter excerpt references standards including ASTM F2503-23 for MR safety marking and ANSI AAMI ST98:2022 for cleaning validation, but the scope of testing or any labeling commitments is not established here.
- Regulatory pathway
- 510(k) premarket notification
- Clinical specialty
- Anesthesiology
- Decision date
- Sep 25, 2026
FDA source record · MedtechLedger’s explanation describes the recorded change.
Regulatory record facts
- Identifier
- K261262
- Regulatory pathway
- 510(k) premarket notification
- Applicant
- Respironics, Inc.
- Product code
- BZD
- Decision code
- SESE
- Decision date
- Sep 25, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Ventilator, Non-Continuous (Respirator).
- Applicant
- Respironics, Inc.
- Product code
- BZD
- FDA device class
- 2
FDA decision timeline
K261262 received
Application receipt date recorded by FDA.
K261262 · FDA decision
SESE
Related devices and submissions
Explore the linked device profile
Other records with product code BZD
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
BreathCare PAP III (YH-390N)K260251 | Suzhou Yuyue Medical Technology Co., Ltd. | 510(k) clearance | Oct 23, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Respironics, Inc.
- Headquarters
- Not reported
- Brand website
- Not reported
- FDA applicant address
- Murrysville, PA
Sources and methodology
- Original FDA record: K261262
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 19, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records